Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20156770rdf:typepubmed:Citationlld:pubmed
pubmed-article:20156770lifeskim:mentionsumls-concept:C0229671lld:lifeskim
pubmed-article:20156770lifeskim:mentionsumls-concept:C0042384lld:lifeskim
pubmed-article:20156770lifeskim:mentionsumls-concept:C0145779lld:lifeskim
pubmed-article:20156770lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:20156770pubmed:dateCreated2010-2-16lld:pubmed
pubmed-article:20156770pubmed:abstractTextVascular injury is the main mechanism in pathophysiology of PR3-ANCA-associated vasculitis. Soluble serum thrombomodulin (sTM) is a membrane-bound receptor for thrombin expressed by vascular endothelial cells. - Objective: The aim of study was to determine the blood levels of sTM in patients with PR3-ANCA-associated vasculitis.lld:pubmed
pubmed-article:20156770pubmed:languageenglld:pubmed
pubmed-article:20156770pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20156770pubmed:citationSubsetIMlld:pubmed
pubmed-article:20156770pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20156770pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20156770pubmed:statusMEDLINElld:pubmed
pubmed-article:20156770pubmed:monthDeclld:pubmed
pubmed-article:20156770pubmed:issn0949-2321lld:pubmed
pubmed-article:20156770pubmed:authorpubmed-author:LukasWWlld:pubmed
pubmed-article:20156770pubmed:authorpubmed-author:ZielonkaT MTMlld:pubmed
pubmed-article:20156770pubmed:authorpubmed-author:WardynK AKAlld:pubmed
pubmed-article:20156770pubmed:authorpubmed-author:KrupaRRlld:pubmed
pubmed-article:20156770pubmed:authorpubmed-author:ZycinskaKKlld:pubmed
pubmed-article:20156770pubmed:issnTypePrintlld:pubmed
pubmed-article:20156770pubmed:day7lld:pubmed
pubmed-article:20156770pubmed:volume14 Suppl 4lld:pubmed
pubmed-article:20156770pubmed:ownerNLMlld:pubmed
pubmed-article:20156770pubmed:authorsCompleteYlld:pubmed
pubmed-article:20156770pubmed:pagination268-70lld:pubmed
pubmed-article:20156770pubmed:meshHeadingpubmed-meshheading:20156770...lld:pubmed
pubmed-article:20156770pubmed:meshHeadingpubmed-meshheading:20156770...lld:pubmed
pubmed-article:20156770pubmed:meshHeadingpubmed-meshheading:20156770...lld:pubmed
pubmed-article:20156770pubmed:meshHeadingpubmed-meshheading:20156770...lld:pubmed
pubmed-article:20156770pubmed:meshHeadingpubmed-meshheading:20156770...lld:pubmed
pubmed-article:20156770pubmed:meshHeadingpubmed-meshheading:20156770...lld:pubmed
pubmed-article:20156770pubmed:meshHeadingpubmed-meshheading:20156770...lld:pubmed
pubmed-article:20156770pubmed:meshHeadingpubmed-meshheading:20156770...lld:pubmed
pubmed-article:20156770pubmed:meshHeadingpubmed-meshheading:20156770...lld:pubmed
pubmed-article:20156770pubmed:year2009lld:pubmed
pubmed-article:20156770pubmed:articleTitleClinical implications of serum thrombomodulin in PR3-ANCA-associated vasculitis.lld:pubmed
pubmed-article:20156770pubmed:affiliationPrimary Systemic Vasculitis Outpatient Clinic, Department of Family Medicine, Internal and Metabolic Diseases, Warsaw Medical University, Warsaw, Poland. kzycinska@poczta.fmlld:pubmed
pubmed-article:20156770pubmed:publicationTypeJournal Articlelld:pubmed
entrez-gene:83580entrezgene:pubmedpubmed-article:20156770lld:entrezgene